Cihan Altın

Cihan Altın serves as an Associate Professor in the Department of Internal Medicine at Izmir University, Turkey, with active faculty status confirmed by current publications and institutional affiliation. His primary email contact is cihan.altin@ieu.edu.tr, and he maintains professional profiles through ORCID (0000-0002-3996-5681), Scopus (23979295100), and YÖK.

His research specializes in cardiovascular medicine, with concentrated expertise in coronary artery disease diagnostics using biomarkers like Pentraxin 3 and Ctrp5, anticoagulation management for atrial fibrillation, and therapeutic strategies for heart failure. He frequently employs coronary computed tomography angiography and real-world data analysis in multicenter studies, examining treatment patterns, dosing accuracy, and clinical outcomes across Turkish patient populations.

Publication trends from 2022-2025 reveal consistent focus on translational cardiology research, particularly biomarker validation for disease severity assessment, SGLT2 inhibitor applications in heart failure, and anticoagulant safety protocols. His work bridges clinical practice with epidemiological analysis, emphasizing practical implementation in Turkish healthcare settings through collaborations with researchers including Umut Kocabas and Taha Okan.

No scientific awards or fellowships were documented in the provided materials.

While student advising activities and grant funding details remain unspecified in available sources, his collaborative publications involving multicenter teams (Anatolia-AF, ROTA, RED-Heart studies) indicate active participation in cardiovascular research networks. Laboratory or dedicated research team affiliations were not explicitly referenced.